Author

H. J. Chen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:spatial transcriptomics· 2 Assay:bulk RNA-seq· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. M. Antonson· 2 shared T. L. Gur· 2 shared A. D. Kenney· 1 shared B. E. Nilsson-Payant· 1 shared B. R. tenOever· 1 shared D. D. Ho· 1 shared D. Nguyen· 1 shared D. Redmond· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. M. Antonson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Moderately pathogenic maternal influenza A virus infection disrupts placental integrity but spares the fetal brain

A. M. Antonson, A. D. Kenney, H. J. Chen, K. N. Corps, J. S. Yount, T. L. Gur

This study shows that moderate maternal influenza A virus infection causes placental issues but not fetal brain inflammation in mice.

bioRxiv · Jan 22, 2021Immunology

Unique maternal immune and functional microbial profiles during prenatal stress

A. M. Antonson, M. V. Evans, J. D. Galley, H. J. Chen, T. A. Rajesekera, S. M. Lammers, V. L. Hale, M. T. Bailey, T. L. Gur

This study identifies immune and microbial profile changes in stressed pregnant mice, showing disrupted maternal-fetal immune balance with both anti- and pro-inflammatory signatures.

bioRxiv · May 26, 2020Immunology

Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids

Y. Han, L. Yang, X. Duan, F. Duan, B. E. Nilsson-Payant, T. M. Yaron, P. Wang, X. Tang, T. Zhang, Z. Zhao, Y. Bram, D. Redmond, S. Houghton, D. Nguyen, D. Xu, , S. Chen

This study uses hPSC-derived lung organoids to identify FDA-approved drugs that inhibit SARS-CoV-2 entry and reduce infection in a model of human COVID-19.

bioRxiv · May 5, 2020 · PreprintMicrobiology